These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7807665)

  • 1. PEPI in perspective. Good answers spawn pressing questions.
    Healy B
    JAMA; 1995 Jan; 273(3):240-1. PubMed ID: 7807665
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan; 273(3):199-208. PubMed ID: 7807658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy.
    Med Lett Drugs Ther; 2002 Sep; 44(1138):78. PubMed ID: 12238487
    [No Abstract]   [Full Text] [Related]  

  • 4. Comment on 'Effect of conjugated estrogen versus conjugated estrogen associated with medroxyprogesterone acetate in postmenopausal women on internal carotid artery pulsatility index: a randomized pilot study'.
    Weiping L; Chenxing L; Enfeng Z
    J Obstet Gynaecol Res; 2012 Mar; 38(3):611-2. PubMed ID: 22353571
    [No Abstract]   [Full Text] [Related]  

  • 5. Consortium for the Assessment of Research on Progestins and Estrogens (CARPE) Fort Worth, Texas August 1-3, 2003.
    Simpkins JW; Singh M
    J Womens Health (Larchmt); 2004 Dec; 13(10):1165-8. PubMed ID: 15650349
    [No Abstract]   [Full Text] [Related]  

  • 6. Estrogen and dementia: insights from the Women's Health Initiative Memory Study.
    Schneider LS
    JAMA; 2004 Jun; 291(24):3005-7. PubMed ID: 15213214
    [No Abstract]   [Full Text] [Related]  

  • 7. Sympathetic skin response in women receiving hormone replacement therapy.
    Kutlar I; Yilmaz M; Balat O
    Int J Gynaecol Obstet; 2004 Feb; 84(2):181-2. PubMed ID: 14871527
    [No Abstract]   [Full Text] [Related]  

  • 8. Ultrastructure study of postmenopausal endometria of tibolone, conjugated estrogen + medroxyprogesterone acetate and tamoxifen users.
    Nas T; Sargon MF; Celik HH; Keskin PO; Gürsoy RH; Biberoglu K
    Saudi Med J; 2007 Dec; 28(12):1917-9. PubMed ID: 18060233
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect on sexual life--a comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate.
    Uygur D; Yeşildaglar N; Erkaya S
    Gynecol Endocrinol; 2005 Apr; 20(4):209-12. PubMed ID: 16019363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of estrogens in women with cardiac disease: what we do not know.
    Sano M; Bell K; Jacobs D
    Am J Med; 2002 Nov; 113(7):612-3. PubMed ID: 12459411
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM; Reboussin DM; Brosnihan KB; Sharp PC; Shumaker SA; Snyder TE; Furberg CD; Kowalchuk GJ; Stuckey TD; Rogers WJ; Givens DH; Waters D
    N Engl J Med; 2000 Aug; 343(8):522-9. PubMed ID: 10954759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of estrogen and medroxyprogesterone on basal and stress-induced growth hormone release, IGF-1 levels, and cellular immunity in postmenopausal women.
    Malarkey WB; Burleson M; Cacioppo JT; Poehlmann K; Glaser R; Kiecolt-Glaser JK
    Endocrine; 1997 Oct; 7(2):227-33. PubMed ID: 9549049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does postmenopausal hormone therapy cause urinary incontinence?
    Rivera R; Gousse A
    Nat Clin Pract Urol; 2006 Jun; 3(6):304-5. PubMed ID: 16763639
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of estrogen-only treatment in postmenopausal women.
    Campagnoli C; Abbà C; Ambroggio S; Peris C
    JAMA; 2004 Aug; 292(6):684; author reply 685-6. PubMed ID: 15304458
    [No Abstract]   [Full Text] [Related]  

  • 15. Women's health. The vanishing promises of hormone replacement.
    Enserink M
    Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract]   [Full Text] [Related]  

  • 16. Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women.
    Wakatsuki A; Okatani Y; Fukaya T
    Circulation; 2002 Dec; 106(24):e198-9; author reply e198-9. PubMed ID: 12473568
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of estrogen-only treatment in postmenopausal women.
    Perlroth FA
    JAMA; 2004 Aug; 292(6):685; author reply 685-6. PubMed ID: 15304461
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of hormonal replacement therapy on C-reactive protein and cell-adhesion molecules in postmenopausal women.
    Lamon-Fava S; Posfai B; Schaefer EJ
    Am J Cardiol; 2003 Jan; 91(2):252-4. PubMed ID: 12521647
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial.
    Barnabei VM; Phillips TM; Hsia J
    J Womens Health Gend Based Med; 1999 Nov; 8(9):1167-72. PubMed ID: 10595329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Food and Drug Administration.
    Crawford LM
    JAMA; 2002 Oct; 288(13):1579. PubMed ID: 12350176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.